| abstract |
The substituted cyclopropyl compounds of formula I and their pharmaceutically acceptable salts are disclosed as being useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included. [Chemical 1] |